Paratek Pharmaceuticals soared while Foamix floundered ahead of market's open.
Mizuho analyst Sheryl Skolnick says investing in credit sensitive equities is the best investment option.
Investors weren't completely distracted by the Affordable Care Act debate.
The biotech company will either pick up assets to grow or sell itself to a larger company in the space, its chief financial officer told a conference.
CEO Joseph Papa takes home approximately $62.7 million yearly.
Valeant shares were down nearly 2% at one point on news that it has completed several refinancing transactions.
Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.
Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.